GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pila Pharma PILA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.62

+1.89%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Pila Pharma — daily PILA

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Pila Pharma on TradingView ↗
Market value
SEK 68.2m
Last close × shares
Volume
36.6k
Shares, 9 Nov 2026

About Pila Pharma

Its shares trade on Nasdaq Stockholm under the ticker PILA.ST. It has been listed since 15 July 2021. In the fiscal year to 31 December 2025, it reported revenue of SEK 1.1m and a net loss of SEK 16.9m. At that date it held total assets of SEK 16.2m and shareholders' equity of SEK 14.8m.

Pila Pharma AB engages in conducting research and experimental pharmaceutical development. The company is headquartered in Malmo, Skane. The company went IPO on 2021-07-15. The firm conducts clinical tests in phase 2 with drugs against type 2 diabetes. The target product is a tablet that is taken orally in an early stage of diabetes to restore the body's insulin production and thereby reduce the patient's blood sugar level. PILA PHARMA's patent-protected product candidate is called XEN-D0501 and is a TRPV1 antagonist, a novel type of oral anti-diabetic agent for treatment of type 2 diabetes. Pila Pharma AB has completed two phase 2a clinical trials (PP-CT01 and PP-CT02), that both demonstrated that XEN-D0501 is well tolerated by people with type 2 diabetes. In addition, the product is expected to have fewer unwanted side effects than alternative forms of treatment.

Figures and description from our data supplier, not checked against the company's own report.

More about Pila Pharma →

Latest on Pila Pharma

Our reporting

We have not reported on Pila Pharma yet.

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of -0.04 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Pila Pharma's ticker?

Pila Pharma trades as PILA.ST on Nasdaq Stockholm, under ISIN SE0015988274.

What was Pila Pharma's last closing price?

1.62 on 9 Nov 2026. The figure is in SEK and is never converted.

When does Pila Pharma next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.